Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of Treatment Patterns for Mucosal Melanoma Using Real-World Data in the SEER-Medicare-Linked Database.

Cancer medicine·2026
Same author

Transmembrane effector substrates of type IV secretion systems: mechanisms of secretion and insertion into host cell membranes.

microLife·2026
Same author

Cerebral Venous Sinus Thrombosis Presenting as an Acute Stroke Syndrome.

Cureus·2026
Same author

Diabetes Belt has lower efficiency in providing diabetes preventive care than surrounding counties.

Health services & outcomes research methodology·2025
Same author

Exploring the social dimensions of AI integration in healthcare: a qualitative study of stakeholder views on challenges and opportunities.

BMJ open·2025
Same author

Development and validation of the telemedicine facilitators scale: A novel measure of telemedicine facilitators and use.

Journal of telemedicine and telecare·2025

Related Experiment Videos

Outcomes associated with pharmacotherapy in overactive bladder.

Monali J Bhosle1, Samuel Wagner, Shashank Ghantoji

  • 1Department of Pharmacy Practice and Administration, Ohio State University, Columbus, OH 43210, USA. bhosle.1@osu.edu

Expert Review of Pharmacoeconomics & Outcomes Research
|October 8, 2009
PubMed
Summary

Overactive bladder (OAB) significantly impacts quality of life, especially in women and older adults. This review details recent pharmacologic treatments and suggests future research directions for OAB management.

Related Experiment Videos

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Overactive bladder (OAB) is a highly prevalent condition in the USA.
  • OAB affects women disproportionately and its prevalence increases with age.
  • While not fatal, OAB significantly diminishes patients' quality of life.

Purpose of the Study:

  • To review recent advancements in overactive bladder treatment.
  • To provide comprehensive information on pharmacotherapeutic outcomes for OAB.

Main Methods:

  • Extensive literature review.
  • Analysis of pharmacotherapeutic agents for OAB.

Main Results:

  • Detailed outcomes of various pharmacologic treatments for OAB.
  • Comparison of efficacy and side effect profiles of different agents.

Conclusions:

  • Pharmacologic agents remain the primary treatment for OAB.
  • Identified areas for future research in OAB pharmacotherapy.
  • Authors provide expert opinions on optimal OAB management strategies.